22nd Century Group Raises $40 Million Selling Shares at $4

22nd Century Announces $40 Million Common Stock Registered Direct Offering Financing Provides Support to the Company’s Strategic Objectives Across All Its Plant Franchises BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today […]